Stock Earnings

Question 1

What are Northwest Biotherapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Northwest Biotherapeutics Inc has a total asset of $26, Net loss of $-85

Question 2

What are the key financial ratios for NWBO?

Accepted Answer

Northwest Biotherapeutics Inc's Current ratio is 0.24, has a Net margin is -8,500, sales per share of $0.

Question 3

How is Northwest Biotherapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Northwest Biotherapeutics Inc largest revenue segment is Innovative Immunotherapies for Cancer, at a revenue of 1,932,000 in the most earnings release.For geography, United States, Germany, United Kingdom and Netherlands is the primary market for Northwest Biotherapeutics Inc, at a revenue of 1,932,000.

Question 4

Is Northwest Biotherapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Northwest Biotherapeutics Inc has a net loss of $-85

Question 5

Does Northwest Biotherapeutics Inc have any liabilities?

Accepted Answer

yes, Northwest Biotherapeutics Inc has liability of 105

Question 6

How many outstanding shares for Northwest Biotherapeutics Inc?

Accepted Answer

Northwest Biotherapeutics Inc has a total outstanding shares of 1,328.6

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	1	1	1	1	1	1
Revenue Growth (YoY)	0%	0%	0%	0%	0%	-50%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	32	33	29	33	33	54
Research & Development	34	34	27	35	20	33
Operating Expenses	66	67	57	68	53	87
Other Non Operating Income (Expenses)	9	6	-2	--	0	--
Pretax Income	-82	-83	-62	-105	179	-529
Income Tax Expense	--	0	0	0	--	--
Net Income	-83	-85	-64	-105	179	-529
Net Income Growth	11%	33%	-39%	-159%	-134%	2,545%
Shares Outstanding (Diluted)	1,438.19	1,242.23	1,119.19	1,015.85	873.52	725.13
Shares Change (YoY)	18%	11%	10%	16%	20%	28.99%
EPS (Diluted)	-0.06	-0.06	-0.05	-0.1	0.21	-0.73
EPS Growth	-7%	19%	-43%	-148%	-129%	1,725%
Free Cash Flow	-45	-58	-57	-55	-44	-38
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	-6,500%	-6,600%	-5,500%	-6,700%	-5,200%	-8,600%
Profit Margin	-8,300%	-8,500%	-6,400%	-10,500%	17,900%	-52,900%
Free Cash Flow Margin	-4,500%	-5,800%	-5,700%	-5,500%	-4,400%	-3,800%
EBITDA	-64	-65	-54	-66	-52	-86
EBITDA Margin	-6,400%	-6,500%	-5,400%	-6,600%	-5,200%	-8,600%
D&A For EBITDA	1	1	1	1	0	0
EBIT	-65	-66	-55	-67	-52	-86
EBIT Margin	-6,500%	-6,600%	-5,500%	-6,700%	-5,200%	-8,600%
Effective Tax Rate	--	0%	0%	0%	--	--

Northwest Biotherapeutics Inc (NWBO) Financial

NWBO Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is NWBO?

NWBO Income

Follow-Up Questions